Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VHT vs. QAAGZX: which is better?

Bottom line

VHT vs QAAGZX: the short answer

VHT (Vanguard Health Care Index Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 79% by weight.

VHT is cheaper at 0.09% vs 0.86% — a difference of $77 a year per $10,000 invested.

Over five years, VHT returned +7.2% a year vs +4.1% for QAAGZX (reporting dates differ).

Updated Nov 19, 2026

VHT vs QAAGZX side by side

VHTQAAGZX
TypeETFETF
Fund familyVanguardT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.09%0.86%
Annual cost per $10k$9$86
10-yr cost on $10k (prospectus)$115$1,061
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+2.7%+18.1%
5-yr return (annualized)+7.2%+4.1%
10-yr return (annualized)+8.8%+9.0%
Best quarter+16.5%+23.4%
Worst quarter−13.1%−15.8%
Net assets (fund)$19.0B$751.7M
Number of holdings407277
Portfolio turnover4%65%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearVHTQAAGZXDifference
2024+2.7%+1.7%+1.0%
2023+2.5%+3.0%−0.5%
2022−5.5%−12.5%+7.0%
2021+20.5%+13.1%+7.4%
2020+18.2%+29.6%−11.4%
2019+22.0%+29.0%−7.0%
2018+5.6%+1.1%+4.4%
2017+23.3%+27.6%−4.2%
2016−3.3%−10.5%+7.2%

Source: Fund prospectus bar charts

Holdings overlap

16 of VHT's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingVHTQAAGZX
Eli Lilly & Co14.04%14.06%
Johnson & Johnson8.47%6.64%
AbbVie Inc6.09%5.12%
UnitedHealth Group Inc5.45%5.88%
Merck & Co Inc4.66%4.00%
Thermo Fisher Scientific Inc2.93%2.53%
Amgen Inc2.87%1.80%
Gilead Sciences Inc2.64%2.79%
Intuitive Surgical Inc2.38%1.89%
Abbott Laboratories2.35%1.91%
Bristol-Myers Squibb Co1.84%2.12%
Danaher Corp1.84%1.44%
CVS Health Corp1.83%0.93%
Vertex Pharmaceuticals Inc1.80%2.26%
Stryker Corp1.66%1.78%

Source: SEC Form N-PORT

VHT top 10

  1. Eli Lilly & Co — 14.04%
  2. Johnson & Johnson — 8.47%
  3. AbbVie Inc — 6.09%
  4. UnitedHealth Group Inc — 5.45%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 2.93%
  7. Amgen Inc — 2.87%
  8. Gilead Sciences Inc — 2.64%
  9. Intuitive Surgical Inc — 2.38%
  10. Pfizer Inc — 2.35%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between VHT and QAAGZX?
VHT (Vanguard Health Care Index Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 79% by weight. VHT is cheaper at 0.09% vs 0.86% — a difference of $77 a year per $10,000 invested.
Which is cheaper, VHT or QAAGZX?
VHT has the lower expense ratio (0.09%).
Should I own both VHT and QAAGZX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.